GenSight Readying to Ask EMA to Approve Gene Therapy for LHON
Leber's hereditary optic neuropathy, News
GenSight Biologics announced it has finished a pre-submission meeting with the European Medicines Agency (EMA), a key step in filing a request for the approval of Lumevoq, its gene therapy for ... Read more